Literature DB >> 6805314

An outbreak of Achromobacter xylosoxidans related to diagnostic tracer procedures.

M B McGuckin, R J Thorpe, K M Koch, A Alavi, M Staum, E Abrutyn.   

Abstract

In December, 1978, an investigation was undertaken to determine the source of infection in five patients in one hospital with hospital-associated bacteremia due to Achromobacter xylosoxidans. Review of their records showed that each had a diagnostic tracer procedure preceding the bacteremia and that no other procedures were common to all. Further investigation revealed that patients from three other hospitals were studied using diagnostic tracer materials from the index hospital. Five patients with confirmed A. xylosoxidans bacteremia and four suspected cases were identified in these hospitals, and all had a scan before the bacteremia was detected. No other A. xylosoxidans isolates were identified in any of the hospitals in the preceding two years. Although not confirmed, the source appeared to be stored non-bacteriostatic saline. Effective control measures included a sterility testing program and use of pre-packaged single dose vials of saline. Diagnostic tracer studies should be added to the list of procedures known to cause hospital-acquired bacteremias.

Entities:  

Mesh:

Year:  1982        PMID: 6805314     DOI: 10.1093/oxfordjournals.aje.a113360

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  12 in total

1.  In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents.

Authors:  Y Glupczynski; W Hansen; J Freney; E Yourassowsky
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

2.  Outbreak of long-term intravascular catheter-related bacteremia due to Achromobacter xylosoxidans subspecies xylosoxidans in a hemodialysis unit.

Authors:  D Tena; R Carranza; J R Barberá; S Valdezate; J M Garrancho; M Arranz; J A Sáez-Nieto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

3.  Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients.

Authors:  Lixia Liu; Tom Coenye; Jane L Burns; Paul W Whitby; Terrence L Stull; John J LiPuma
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

4.  Achromobacter xylosoxidans infection presenting as a pulmonary nodule mimicking cancer.

Authors:  Stephanie L Claassen; Jason M Reese; Vincent Mysliwiec; Steven D Mahlen
Journal:  J Clin Microbiol       Date:  2011-05-18       Impact factor: 5.948

5.  Achromobacter spp. bacteremia outbreak related to contaminated furosemide ampoules.

Authors:  Rajalakshmi Arjun; Kalpana E John; Vettakkara Kandy Muhammed Niyas; Sreerekha R Nair; Viji Mohan; Raveendran Sarala Ratheesh
Journal:  Infez Med       Date:  2021-09-10

6.  Infections due to Achromobacter xylosoxidans. Case report and review of the literature.

Authors:  P H Chandrasekar; E Arathoon; D P Levine
Journal:  Infection       Date:  1986 Nov-Dec       Impact factor: 3.553

7.  Epidemiological typing of clinical isolates of Achromobacter xylosoxidans: comparison of phenotypic and genotypic methods.

Authors:  M Kaur; P Ray; M Bhatty; M Sharma
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-04-17       Impact factor: 3.267

Review 8.  Achromobacter xylosoxidans (Alcaligenes xylosoxidans subsp. xylosoxidans) bacteremia associated with a well-water source: case report and review of the literature.

Authors:  J B Spear; J Fuhrer; B D Kirby
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

9.  Diversity of plasmids in Achromobacter xylosoxidans isolates responsible for a seemingly common-source nosocomial outbreak.

Authors:  J C Arroyo; W Jordan; M W Lema; A Brown
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

10.  Outbreak of Achromobacter xylosoxidans and Ochrobactrum anthropi Infections after Prostate Biopsies, France, 2014.

Authors:  Skerdi Haviari; Pierre Cassier; Cédric Dananché; Monique Hulin; Olivier Dauwalder; Olivier Rouvière; Xavier Bertrand; Michel Perraud; Thomas Bénet; Philippe Vanhems
Journal:  Emerg Infect Dis       Date:  2016-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.